BRIEF published on 08/25/2025 at 10:01, 1 year ago Threshold crossing for Inventiva Actions AMF Threshold Crossing Inventiva Great Point Partners
BRIEF published on 08/19/2025 at 15:40, 1 year ago JP Morgan crosses threshold in INVENTIVA Actions Financial Market JP Morgan Crossing InVentura
BRIEF published on 08/19/2025 at 15:37, 1 year ago JP Morgan Chase exceeds 5% threshold in Inventiva Capital Actions Threshold Crossing JP Morgan Inventiva
BRIEF published on 08/12/2025 at 16:02, 1 year 1 month ago JP Morgan crosses threshold at INVENTIVA Voting Rights Threshold Crossing JP Morgan Inventiva Assimilation
BRIEF published on 08/12/2025 at 15:57, 1 year 1 month ago Threshold crossings by JP Morgan at Inventiva Voting Rights Actions Threshold Crossing JP Morgan Inventiva
BRIEF published on 08/11/2025 at 22:05, 1 year 1 month ago Inventiva at Canaccord Genuity 45th Annual Growth Conference Conference Biopharmaceuticals MASH Lanifibranor Clinical Advances
PRESS RELEASE published on 08/11/2025 at 22:00, 1 year 1 month ago Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference Inventiva to participate in fireside chat at Canaccord Genuity 45th Annual Growth Conference on August 13, 2025, to discuss lanifibranor and R&D strategy Fireside Chat Inventiva Lanifibranor R&D Strategy Canaccord Genuity Conference
BRIEF published on 07/31/2025 at 22:05, 1 year 1 month ago Inventiva's Half-Year Liquidity Contract Review with Kepler Cheuvreux Liquidity Contract Kepler Cheuvreux Clinical Trials Inventiva Stock Performance
PRESS RELEASE published on 07/31/2025 at 22:00, 1 year 1 month ago Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Inventiva announces half-year review of liquidity contract with Kepler Cheuvreux, revealing resources available in the liquidity account as of June 30, 2025 Liquidity Contract Kepler Cheuvreux Inventiva Resources Available Half-year Review
BRIEF published on 07/09/2025 at 22:10, 1 year 2 months ago Strategic appointments at Inventiva to strengthen R&D and regulatory affairs Appointments R&D Regulatory Affairs Inventiva MASH
Published on 09/18/2026 at 00:55, 3 hours 35 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 4 hours 5 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 6 hours 15 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 6 hours 15 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 6 hours 25 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 19:00, 9 hours 29 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 9 hours 31 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 10 hours 4 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 10 hours 19 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 10 hours 43 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 10 hours 50 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 10 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 21 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
